Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$135,418
+$85,506 QoQ
Shares Held
12,996
+60.1% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 95 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. RNAC ranks #267 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in RNAC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $135,418 12,996
2026-03-31 $49,912 8,116
2025-12-31 $58,486 8,112
2025-09-30 $75,872 7,424
2025-06-30 $77,135 7,424
2025-03-31 $97,847 7,424
2024-12-31 $65,155 3,638
2024-09-30 $58,643 3,638
2024-06-30 $98,261 3,638
2024-03-31 $42,779 65,815
2023-12-31 $45,346 65,815
2023-09-30 $69,763 65,815
2022-09-30 $913,932 557,276
2022-06-30 $726,706 554,738
2022-03-31 $945,392 768,613
2021-12-31 $2,525,029 774,549
2021-09-30 $2,494,913 599,739
2021-06-30 $2,784,309 666,103
2021-03-31 $3,466,827 766,150
2020-12-31 $2,195,403 724,556
2020-09-30 $89,901 36,251
2020-06-30 $88,650 31,215